Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment. Hogan MP, Horvat JV, Ross DS, Sevilimedu V, et al. Breast Cancer Res Treat 2023;198:349-359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hogan MP, Horvat JV, Ross DS, Sevilimedu V, et al. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment. Breast Cancer Res Treat 2023;198:349-359.
PMID: 36754936